LONDON (Reuters) - U.S. law firm Gardy & Notis, a shareholder rights advocate, said on Wednesday it was investigating AbbVie and its officers over statements made in connection with the drugmaker's failed move to buy Dublin-based Shire .
Gardy & Notis said it was asking investors to get in touch if they had lost money after buying SHIRE (SHP.LO)American Depository Receipts between June 20 and Oct. 14.
ABBVIE (ABBV.NY)Chief Executive Richard Gonzalez told investors in July that expected tax benefits were "not the primary rationale" for the combination but, in reality, the law firm said tax was a critical factor.
The U.S. firm ditched the planned $55 billion takeover after the U.S. government announced a change in treatment of so-called tax inversions, sending Shire shares into a tailspin.
(Reporting by Ben Hirschler; Editing by Greg Mahlich)
Relacionados
- Abbvie pagará 1.300 millones al retirar su oferta por su rival Shire
- Primera víctima de la reforma fiscal de Obama: AbbVie prefiere indemnizar a la británica Shire y no comprarla
- Economía.- La farmacéutica estadounidense AbbVie no comprará Shire e indemnizará con 1.287 millones a la británica
- AbbVie renuncia a comprar la británica Shire tras la reforma de la fiscalidad en EE.UU
- AbbVie renuncia a comprar la británica Shire tras la reforma de la fiscalidad en EEUU